Mbx Biosciences Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$65.93

-0.53 (-0.80%)

As of Aug 8, 1:38 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 88%

Hold 1 6%

Sell 1 6%

Price Target

Analyst Price Target -28.5% upside

Low Target $32.34

Average Target $47.13

High Target $55.83

Current Price $65.93

Current
$65.93

Target
$47.13

$32.34 $47.13 avg $55.83

Scenario Analysis

Bear Case

$32.34

-50.9%

Low target

Base Case

$47.13

-28.5%

Avg target

Bull Case

$55.83

+-15.3%

High target

Risk/Reward

0.3x

Unfavorable

Price in Context

52-Week High

$72.64

-9.2% from high

52-Week Low

$9.63

+584.6% from low

Target vs 52W High

$47.13

-35.1% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+12.2%
RDY Dr. Reddy's Laboratories	Sell	44	52%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	68%	$299.55	+15.5%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+23.9%
PFE Pfizer Inc.	Hold	36	42%	$33.90	+26.7%
BMY Bristol-Myers Squibb Co	Hold	35	40%	$174.50	+169.6%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-36.1%
ZTS Zoetis Inc	Hold	24	54%	$209.87	+188.8%